Answers are grounded in this paper and cite their sources.
Schistosomiasis is a neglected tropical disease caused by blood-transmitted trematode worms of the genus Schistosoma and is endemic in several parts of Africa, the Middle East, South-East Asia and South America. Schistosomiasis is the most common neglected tropical disease, affecting an estimated 206 million people in 76 countries. Schistosoma mansoni, S. japonicum and S. mekongi cause intestinal disease, while S. haematobium and some stray infections of S. japonicum cause urogenital schistosomiasis. Schistosomiasis is classified as a neglected tropical disease due to the lack of research and development of new diagnostics, therapeutics or vaccines to control the disease. A single oral dose of praziquantel has been the first-line treatment for schistosomiasis for nearly four decades. Although generally effective against juvenile and adult worms, praziquantel is less effective against developing stages. Public health concerns have been raised by recent reports of reduced susceptibility to praziquantel in some strains of schistosoma. The identification of new schistosomicidal compounds with novel mechanisms of action is essential. Transition metal complexes with organic ligands exhibit a wide range of pharmacological properties, including antimicrobial, antiviral, antitumour and antiparasitic activities. Phenanthroline, a bicyclic aromatic compound, is a well-studied organic ligand that forms complexes with several transition metal ions, including copper, cobalt, zinc, silver, platinum and iron. These transition metal-phenanthroline complexes are bioactive against bacteria, Trypanosoma cruzi, Leishmania amazonensis, Hela and breast adenocarcinoma cells. 1,10-phenanthroline derivatives are aromatic compounds containing a chelating nitrogen base. This study evaluated the in vitro anthelmintic activity of 1,10-phenanthroline derivatives against S. mansoni and S. japonicum using an in vitro adult worm assay. This is the first study to evaluate the anthelmintic activity of 1,10-phenanthroline derivatives against Schistosoma species.
No takes yet. Share an insight, caveat, or question.
Shehab et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: